Table 1—

Characteristic of transplant recipients studies

Male24 (56)
Age yrs51 (43–60)
Disease
 COPD15 (35)
 A1AT11 (26)
 IPF6 (14)
 PPH4 (9)
 Other7 (15)
Time since transplantation months17 (8–61)
Single lung transplant26 (60)
Cyclosporine use23 (53)
 Cyclosporine level ng·mL−1386 (299–496)
Tacrolimus use20 (47)
 Tacrolimus level ng·mL−110.8 (8.7–15.35)
Azathioprine use29 (67)
Mycophenelate use7 (16)
Prednisone daily dose mg10 (7.5–15)
Absolute lymphocyte count K·uL1.24 (0.94–1.65)
IgG level mg·dL−1577 (445–753)
Creatinine µmol·L−1150 (114–220)
  • Data are presented as n (%) or mean (interquartile ranges)

  • COPD: chronic obstructive pulmonary disease

  • A1AT: alph-1-antitrypsin deficiency

  • IPF: idopathie pulmonary fibrosis

  • PPH: primary pulmonary hypertension

  • IgG: immunoglobulin-G